Regenicin OverviewRegenicin Operating Income
Operating Income for RGIN.
Quarterly Operating Income
N/A
As of Sep 30, 2023
Annual Operating Income (TTM)
$-630761.00
↑ 4.55% YoY
Trailing 12 months ending Sep 30, 2023
Regenicin OverviewOperating Income for RGIN.
As of Sep 30, 2023
Trailing 12 months ending Sep 30, 2023